• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Lymph Node Spread Varies Widely Across Soft-Tissue Sarcoma Types in Extremity Tumors

by
November 13, 2026
in Cancer, Health
Reading Time: 3 mins read
0
Lymph Node Spread Varies Widely Across Soft-Tissue Sarcoma Types in Extremity Tumors

Lymph Node Spread Varies Widely Across Soft-Tissue Sarcoma Types in Extremity Tumors

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Regional lymph node involvement in malignant extremity soft-tissue sarcoma varies substantially depending on the histologic subtype of the tumor, according to an observational analysis of registry records from the Surveillance, Epidemiology, and End Results program. Although spread to regional lymph nodes is uncommon overall among patients presenting with soft-tissue sarcomas of the extremities, investigators found that specific histological classifications carry markedly different frequencies of nodal disease and that nodal positivity remains linked to reduced cancer-specific survival.

To evaluate these histology-specific patterns and their prognostic implications, researchers analyzed malignant extremity soft-tissue sarcoma cases diagnosed between 2018 and 2023. The cohort was derived using an audited, reproducible International Classification of Diseases for Oncology, Third Edition morphology code set. The investigation was designed to clarify contemporary rates of regional nodal involvement across distinct tumor types and to determine how nodal disease tracks with survival outcomes in recorded clinical practice.

Across the identified population, the researchers evaluated a total of 9,311 eligible cases of extremity soft-tissue sarcoma. Among these patients, 8,636 individuals had documented nodal status available for evaluation in the registry. Within this evaluated group, 376 patients, representing 4.4 percent of those with known nodal status, were identified as having regional node-positive disease, confirming that regional nodal presentation is relatively infrequent across the overall extremity sarcoma population.

The frequency of regional lymph node positivity differed sharply when the cohort was broken down by specific histologic subtypes. Recorded nodal positivity was highest among patients diagnosed with rhabdomyosarcoma at 30.9 percent, followed closely by clear cell sarcoma at 29.0 percent. Patients with epithelioid sarcoma demonstrated a 20.8 percent rate of nodal involvement, while those with angiosarcoma presented with a 13.7 percent rate of regional nodal positivity.

Multivariable logistic regression modeling was utilized to assess the adjusted odds of presenting with node-positive disease across the various histologic groups. In these adjusted comparisons, the odds of nodal involvement were highest for clear cell sarcoma, which demonstrated an adjusted odds ratio of 17.72. Rhabdomyosarcoma showed an adjusted odds ratio of 7.47, and epithelioid sarcoma showed an adjusted odds ratio of 6.82. In contrast, synovial sarcoma was not statistically associated with higher odds of nodal involvement relative to liposarcoma, yielding an odds ratio of 1.15 with a 95 percent confidence interval spanning 0.60 to 2.20.

The study also assessed the relationship between regional nodal involvement and cancer-specific survival using two Cox proportional hazards models and a Fine-Gray competing-risk analysis. In a tumor-adjusted Cox model, node-positive disease was associated with worse cancer-specific survival, yielding a hazard ratio of 1.46 with a 95 percent confidence interval ranging from 1.22 to 1.73. Following additional statistical adjustment for treatment factors, node-positive disease remained associated with poorer cancer-specific survival, showing an adjusted hazard ratio of 1.35 with a 95 percent confidence interval between 1.13 and 1.60.

To test the stability of the observed histology findings, the investigators conducted sensitivity analyses restricted to adult-only cases as well as nonmetastatic-only cases. The findings from these sensitivity analyses, alongside the competing-risk survival evaluations, were consistent with the primary results, demonstrating that the wide differences in nodal involvement across histological classifications were not driven solely by pediatric cases or distant metastatic spread at presentation.

The authors concluded that while recorded regional nodal involvement varies substantially by histologic subtype and correlates with worse cancer-specific survival, the observational data carry inherent limitations. The researchers emphasized that these observational registry findings support further clinical evaluation of histology-informed nodal assessment but do not establish that adopting any specific nodal staging strategy directly improves patient outcomes.

Subject of Research: Regional lymph node involvement and survival across histologic subtypes in extremity soft-tissue sarcoma

Article Title: Regional lymph node involvement varies by histologic subtype in extremity soft-tissue sarcoma

Article References: Alzahrani, M., Dabroom, A., & Alzahrani, Z. (2026). Regional lymph node involvement varies by histologic subtype in extremity soft-tissue sarcoma. Discover Oncology. https://doi.org/10.1007/s12672-026-06218-z

Image Credits: AI Generated

DOI: 10.1007/s12672-026-06218-z

Keywords: soft-tissue sarcoma, extremity sarcoma, lymph node involvement, histologic subtypes, clear cell sarcoma, rhabdomyosarcoma, epithelioid sarcoma, angiosarcoma, synovial sarcoma, liposarcoma, SEER database, cancer-specific survival, multivariable logistic regression, Cox proportional hazards, Fine-Gray competing risk, oncology registry analysis

News Source: Nathaniel Bowman. (November 13, 2026). Lymph Node Spread Varies Widely Across Soft-Tissue Sarcoma Types in Extremity Tumors. Scienmag.

Tags: angiosarcomacancer-specific survivalclear cell sarcomaCox proportional hazardsepithelioid sarcomaextremity sarcomaFine-Gray competing riskhistologic subtypesliposarcomalymph node involvementmultivariable logistic regressiononcology registry analysisrhabdomyosarcomaSEER databasesoft tissue sarcomasynovial sarcoma
Share12Tweet7Share2ShareShareShare1

Related Posts

Field Necropsies Reveal Most Removed Spanish Sows Harbor Concurrent Macroscopic Lesions

Field Necropsies Reveal Most Removed Spanish Sows Harbor Concurrent Macroscopic Lesions

November 17, 2026
Acute Multisystem Mitochondrial Disease Linked to SDHA Variant in Family Pedigree

Acute Multisystem Mitochondrial Disease Linked to SDHA Variant in Family Pedigree

November 17, 2026

Non-Prescribed Gabapentinoid Use Associates With Novel Psychoactive Substances in US Survey

November 17, 2026

Hardystonite-Reinforced Poly(ε-caprolactone) Membranes Evaluated for Guided Bone Regeneration

November 17, 2026

POPULAR NEWS

  • Alloplastic Temporomandibular Joint Replacement Offers Uncertain Benefits After Mandibular Neoplasm Resection

    Alloplastic Temporomandibular Joint Replacement Offers Uncertain Benefits After Mandibular Neoplasm Resection

    29 shares
    Share 12 Tweet 7
  • Serum Mass Spectrometry Predicts Treatment Response in HER2-Positive Breast Cancer

    29 shares
    Share 12 Tweet 7
  • Polypharmacy Linked to Higher Odds of Sarcopenia in Older Adults

    29 shares
    Share 12 Tweet 7
  • Adapted Virtual Presence Tool Proves Feasible in Pilot Manikin Simulation Courses

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Field Necropsies Reveal Most Removed Spanish Sows Harbor Concurrent Macroscopic Lesions

Bimetallic Gold and Rhodium Catalyst Drives Efficient Electrochemical Nitroarene Reduction

Acute Multisystem Mitochondrial Disease Linked to SDHA Variant in Family Pedigree

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.